 |
 |
 |
|
| 20-06-2012 |
 |
XCELIA supplies the first biomedical pharmaceutical products |
This Banc de Sang i Teixits’ division has begun producing pharmaceutical products to treat patients suffering from chronic knee osteoarthritis using the patient’s own stem cells. It is the first time a public corporation has manufactured pharmaceutical products for advanced cellular treatment.
XCELIA will attend BIO Boston with the Catalan delegation organised by Biocat and composed of 50 companies from the biomedical industry.

Attached file |
|
 |
|
|
| 28-11-2011 |
 |
The BST develops 36 research projects in 2010 |
The Blood and Tissue Bank (BST) has just edited the 2010 scientific report, which contains the most relevant actions, scientific advances and the development of new research projects led by the team of experts who are part of the organization.
Active projects in 2010 have been in the field of diagnosis and biomarkers (15), blood technology and transfusion medicine (12), and in the field of advanced cell therapies (9).

Attached file |
|
 |
|
|
| 15-07-2011 |
 |
XCELIA is presented publicly |
Advanced Therapies Division of Banc de Sang i Teixits has
exposed to the BST his mission, focused on promoting
health through the development of secure and personalized
medicine based on cell therapy and engineering

Attached file |
|
 |
|
 |
more news |
|
 |

|